|
| Status |
Public on Jun 08, 2022 |
| Title |
Modification of gene expression in prostate cancer cells treated with Perfluorooctanoic acid |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
DU145 (human prostate cancer cell line) were treated with different concentrations of Perfluorooctanoic acid (PFOA) : 10-6, 10-9 and 10-12M for 48h and modifications of gene expression were analyzed.
|
| |
|
| Overall design |
The experiement includes the treatment with three concentrations of PFOA (10-6, 10-9, 10-12 M) and a control condition (treatment with EtOH, solvent). Each conditions are in duplicate.
|
| |
|
| Contributor(s) |
Clavel S, Charazac A, Hinault C, Dolfi B, Hautier S, Decondé Le Butor C, Bost F, Chevalier N |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
May 15, 2020 |
| Last update date |
Jun 09, 2022 |
| Contact name |
Kevin Lebrigand |
| Organization name |
IPMC/CNRS
|
| Lab |
Functional Genomics Platform of Nice-Sophia-Antipolis, France.
|
| Street address |
660 route des lucioles
|
| City |
Valbonne - Sophia-Antipolis |
| ZIP/Postal code |
06560 |
| Country |
France |
| |
|
| Platforms (1) |
| GPL21185 |
Agilent-072363 SurePrint G3 Human GE v3 8x60K Microarray 039494 [Probe Name Version] |
|
| Samples (8)
|
|
| Relations |
| BioProject |
PRJNA633102 |
Less...
More...